Circulating Plasma Biomarkers of Survival in Antifibrotic-Treated Patients With Idiopathic Pulmonary Fibrosis

BACKGROUND: A number of circulating plasma biomarkers have been shown to predict survival in patients with idiopathic pulmonary fibrosis (IPF), but most were identified before the use of antifibrotic (AF) therapy in this population. Because pirfenidone and nintedanib have been shown to slow IPF prog...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chest
Hauptverfasser: Adegunsoye, Ayodeji, Alqalyoobi, Shehabaldin, Linderholm, Angela, Bowman, Willis S., Lee, Cathryn T., Pugashetti, Janelle Vu, Sarma, Nandini, Ma, Shwu-Fan, Haczku, Angela, Sperling, Anne, Strek, Mary E., Noth, Imre, Oldham, Justin M.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American College of Chest Physicians 2020
Schlagworte:
Diffuse Lung Disease: Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7545483/
https://ncbi.nlm.nih.gov/pubmed/32450241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chest.2020.04.066
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge